Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 2.137 Q1 | 103 | 94 | 232 | 8928 | 1118 | 220 | 4.78 | 94.98 | 36.19 | |
2 | Current Medicinal Chemistry | journal | 1.699 Q1 | 202 | 430 | 828 | 53487 | 4696 | 823 | 5.48 | 124.39 | 38.00 | |
3 | Current Molecular Pharmacology | journal | 1.689 Q1 | 49 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | 36.23 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.468 Q1 | 96 | 99 | 188 | 10725 | 777 | 168 | 4.07 | 108.33 | 33.55 | |
5 | Current Drug Targets | journal | 1.461 Q1 | 119 | 193 | 419 | 21891 | 1600 | 379 | 3.72 | 113.42 | 35.54 | |
6 | Current Pharmaceutical Design | journal | 1.414 Q1 | 183 | 405 | 1128 | 48213 | 4871 | 1016 | 4.21 | 119.04 | 37.43 | |
7 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.341 Q1 | 108 | 114 | 262 | 10207 | 950 | 234 | 3.16 | 89.54 | 33.73 | |
8 | Current Neuropharmacology | journal | 1.309 Q1 | 103 | 94 | 102 | 7032 | 445 | 97 | 3.51 | 74.81 | 35.27 | |
9 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.961 Q2 | 43 | 28 | 85 | 2577 | 251 | 84 | 1.96 | 92.04 | 27.08 | |
10 | Current Vascular Pharmacology | journal | 0.944 Q2 | 69 | 74 | 182 | 7940 | 580 | 169 | 3.21 | 107.30 | 24.70 | |
11 | Open Medicinal Chemistry Journal | journal | 0.921 Q2 | 23 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | 56.00 | |
12 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 Q2 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | 37.46 | |
13 | Infectious Disorders - Drug Targets | journal | 0.778 Q2 | 61 | 48 | 131 | 4761 | 341 | 115 | 2.68 | 99.19 | 30.65 | |
14 | Reviews on Recent Clinical Trials | journal | 0.718 Q2 | 35 | 30 | 75 | 2410 | 171 | 74 | 2.31 | 80.33 | 34.23 | |
15 | Current Drug Safety | journal | 0.526 Q2 | 41 | 57 | 112 | 2359 | 238 | 102 | 2.05 | 41.39 | 34.64 | |
16 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.497 Q2 | 45 | 18 | 97 | 1059 | 156 | 93 | 1.22 | 58.83 | 47.46 | |
17 | Anti-Infective Agents | journal | 0.364 Q3 | 26 | 0 | 68 | 0 | 71 | 65 | 0.77 | 0.00 | 0.00 | |
18 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q3 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | 41.79 | |
19 | Current Radiopharmaceuticals | journal | 0.226 Q3 | 32 | 40 | 55 | 2644 | 35 | 50 | 0.64 | 66.10 | 25.20 | |
20 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.179 Q3 | 27 | 36 | 111 | 3401 | 43 | 101 | 0.52 | 94.47 | 43.02 | |
21 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.126 Q4 | 17 | 33 | 93 | 3010 | 24 | 85 | 0.22 | 91.21 | 47.19 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®